EUROPE POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027
The Point of care diagnostic (POC) tests refers to the diagnostic procedures, which are conducted outside the laboratories. The Europe Point of care diagnostic market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 8.67% during the forecast period. The technological advancements in POC diagnostic devices and introduction of home-based POC devices, and an increase in healthcare spending also support the growth of the market.
EUROPE POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2027
Europe Point of Care Diagnostics Market by Mode of Prescription (Prescription Based Devices, Otc Based Devices) by End-user (Professional Diagnostic Centers, Research Laboratories, Home Care, Other End-user) by Product Type (Glucose Monitoring Kits, Infectious Diseases Testing Kits, Pregnancy and Fertility Testing Kits, Hematology Testing Kits, Cardiometabolic Monitoring Kits, Urinalysis Testing Kits, Coagulation Monitoring Kits, Tumor/cancer Markers Testing Kits, Cholesterol Testing Trips, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Other Product) by Geography.
The Point of care diagnostic (POC) tests refers to the diagnostic procedures, which are conducted outside the laboratories. The Europe Point of care diagnostic market was valued at $XX million in 2018 and is expected to reach $XX million by 2027 with a CAGR of 8.67% during the forecast period.
The technological advancements in POC diagnostic devices and introduction of home-based POC devices, and an increase in healthcare spending also support the growth of the market.
The growing prevalence of chronic and infectious diseases, the rise in the implementation of healthcare reforms, and the rising demand for decentralized chronic and infectious disease testing are primarily driving the market growth.
The European market for rapid point of care testing is the dynamic and robust market attributed to major technological advances and developments in the region. Major pharmaceutical and biotechnology entities with the help of distributors supply products in the market to promote the self-testing concept are expected to fuel the growth of the segment. Furthermore, the conferences organized by various players in the market on point of care devices focusing on crucial factors for the success of point of care testing such as interoperability of technology coupled with implementation, and data management are expected to boost the further advancements in the sector and in turn are anticipated to drive the market in coming years.
The economies of the United Kingdom, France, Germany, Spain, Italy, and the Rest of Europe are the major revenue contributors to the Europe market. France is among the biggest consumers of pharmaceutical products in the world and one of the most complex markets to commercialize pharmaceutical products.
Abbott, Quest Diagnostics Inc., Chembio Diagnost ICS Systems, Inc., Gene POC, Bio-Rad Laboratories, Inc., Trivitron Healthcare, Cardinal Health Inc., Sight Diagnostics Ltd., Biomérieux SA, Siemens Healthineers, Trinity Biotech, Becton Dickinson and Company, Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and Ortho Clinical Diagnostics are the major companies operating in the region.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP-DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- INFECTIOUS DISEASE TESTING KIT IS THE FASTEST GROWING PRODUCT TYPE DURING THE FORECAST PERIOD
- PROFESSIONAL DIAGNOSTIC CENTERS ARE THE MAJOR END-USER IN POINT OF CARE MARKET
- PRESCRIPTION BASED DEVICES ARE THE FREQUENTLY USED MODE OF PRESCRIPTION
- MARKET DYNAMICS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- GROWING PREVALENCE OF CHRONIC AND INFECTIOUS DISEASES
- RISE IN THE IMPLEMENTATION OF HEALTHCARE REFORMS
- RISING DEMAND FOR DECENTRALIZED CHRONIC AND INFECTIOUS DISEASE TESTING
- MARKET RESTRAINTS
- STRINGENT REGULATION
- INSUFFICIENT REIMBURSEMENT POLICIES
- MARKET OPPORTUNITIES
- REDUCTION IN THE HEALTHCARE COST FACILITATES
- RISING INCIDENCES AND PREVALENCE RATES OF VARIOUS INFECTIOUS DISEASES
- GROWING NUMBER OF SMARTPHONE EMPOWERS PATIENTS TO MONITOR THEIR CLINICAL CONDITION ONLINE
- MARKET CHALLENGES
- CHALLENGES RELATED TO THE EXECUTION OF HIGHLY SENSITIVE DEVICES
- VARIATION IN TEST RESULTS
- DIFFICULTIES ASSOCIATED IN DATA MANAGEMENT
- MARKET BY MODE OF PRESCRIPTION
- PRESCRIPTION BASED DEVICES
- OTC BASED DEVICES
- MARKET BY END-USER
- PROFESSIONAL DIAGNOSTIC CENTERS
- RESEARCH LABORATORIES
- HOME CARE
- OTHER END-USER
- MARKET BY PRODUCT TYPE
- GLUCOSE MONITORING KITS
- INFECTIOUS DISEASES TESTING KITS
- PREGNANCY AND FERTILITY TESTING KITS
- HEMATOLOGY TESTING KITS
- CARDIOMETABOLIC MONITORING KITS
- URINALYSIS TESTING KITS
- COAGULATION MONITORING KITS
- TUMOR/CANCER MARKERS TESTING KITS
- CHOLESTEROL TESTING TRIPS
- DRUGS OF ABUSE TESTING KITS
- FECAL OCCULT TESTING KITS
- OTHER PRODUCT
- KEY ANALYTICS
- PORTER’S FIVE FORCES MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- THREAT OF COMPETITIVE RIVALRY
- POLITICAL & LEGAL, ECONOMIC AND TECHNOLOGICAL ANALYSIS
- REGULATORY FRAMEWORK
- PATENT ANALYSIS
- ETYMOLOGY OF POINT OF CARE MARKET
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCES MODEL
- GEOGRAPHICAL ANALYSIS
- EUROPE
- GERMANY
- FRANCE
- THE UNITED KINGDOM
- ITALY
- SPAIN
- REST OF EUROPE
- EUROPE
- COMPANY PROFILES
- ABBOTT
- BECTON DICKINSON AND COMPANY
- BIOMÉRIEUX SA
- BIO-RAD LABORATORIES, INC.
- CARDINAL HEALTH INC.
- CHEMBIO DIAGNOST ICS SYSTEMS, INC.
- DANAHER CORPORATION
- GENE POC
- HOFFMANN-LA ROCHE LTD.
- ORTHO CLINICAL DIAGNOSTICS
- QUEST DIAGNOSTICS INC.
- SIEMENS HEALTHINEERS
- SIGHT DIAGNOSTICS LTD.
- THERMO FISHER SCIENTIFIC INC.
- TRINITY BIOTECH
- TRIVITRON HEALTHCARE
LIST OF TABLES
TABLE 1 EUROPE POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
TABLE 2 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY MODE OF PRESCRIPTION 2019-2027 ($ MILLION)
TABLE 3 EUROPE PRESCRIPTION BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 4 EUROPE OTC BASED DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 5 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 6 EUROPE PROFESSIONAL DIAGNOSTIC CENTERS MARKET 2019-2027 ($ MILLION)
TABLE 7 EUROPE RESEARCH LABORATORIES MARKET 2019-2027 ($ MILLION)
TABLE 8 EUROPE HOME CARE MARKET 2019-2027 ($ MILLION)
TABLE 9 EUROPE OTHER END-USER MARKET 2019-2027 ($ MILLION)
TABLE 10 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY PRODUCT TYPE 2019-2027 ($ MILLION)
TABLE 11 EUROPE GLUCOSE MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 12 EUROPE INFECTIOUS DISEASES TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 13 EUROPE PREGNANCY AND FERTILITY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 14 EUROPE HEMATOLOGY TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 15 EUROPE CARDIOMETABOLIC MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 16 EUROPE URINALYSIS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 17 EUROPE COAGULATION MONITORING KITS MARKET 2019-2027 ($ MILLION)
TABLE 18 EUROPE TUMOR/CANCER MARKERS TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 19 EUROPE CHOLESTEROL TESTING TRIPS MARKET 2019-2027 ($ MILLION)
TABLE 20 EUROPE DRUGS OF ABUSE TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 21 EUROPE FECAL OCCULT TESTING KITS MARKET 2019-2027 ($ MILLION)
TABLE 22 EUROPE OTHER PRODUCT MARKET 2019-2027 ($ MILLION)
TABLE 23 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY COUNTRY 2019-2027 ($ MILLION)
LIST OF FIGURES
FIGURE 1 EUROPE POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 2 EUROPE POINT OF CARE DIAGNOSTICS MARKET SHARE BY MODE OF PRESCRIPTION 2018 & 2027 (%)
FIGURE 3 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY PRESCRIPTION BASED DEVICES 2019-2027 ($ MILLION)
FIGURE 4 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY OTC BASED DEVICES 2019-2027 ($ MILLION)
FIGURE 5 EUROPE POINT OF CARE DIAGNOSTICS MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 6 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY PROFESSIONAL DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
FIGURE 7 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY RESEARCH LABORATORIES 2019-2027 ($ MILLION)
FIGURE 8 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY HOME CARE 2019-2027 ($ MILLION)
FIGURE 9 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY OTHER END-USER 2019-2027 ($ MILLION)
FIGURE 10 EUROPE POINT OF CARE DIAGNOSTICS MARKET SHARE BY PRODUCT TYPE 2018 & 2027 (%)
FIGURE 11 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY GLUCOSE MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 12 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY INFECTIOUS DISEASES TESTING KITS 2019-2027 ($ MILLION)
FIGURE 13 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY PREGNANCY AND FERTILITY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 14 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY HEMATOLOGY TESTING KITS 2019-2027 ($ MILLION)
FIGURE 15 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY CARDIOMETABOLIC MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 16 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY URINALYSIS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 17 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY COAGULATION MONITORING KITS 2019-2027 ($ MILLION)
FIGURE 18 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY TUMOR/CANCER MARKERS TESTING KITS 2019-2027 ($ MILLION)
FIGURE 19 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY CHOLESTEROL TESTING TRIPS 2019-2027 ($ MILLION)
FIGURE 20 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY DRUGS OF ABUSE TESTING KITS 2019-2027 ($ MILLION)
FIGURE 21 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY FECAL OCCULT TESTING KITS 2019-2027 ($ MILLION)
FIGURE 22 EUROPE POINT OF CARE DIAGNOSTICS MARKET BY OTHER PRODUCT 2019-2027 ($ MILLION)
FIGURE 23 PORTER’S FIVE FORCE MODEL
FIGURE 24 GERMANY POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 25 FRANCE POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 26 THE UNITED KINGDOM POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 27 ITALY POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 28 SPAIN POINT OF CARE DIAGNOSTICS MARKET 2019-2027 ($ MILLION)
FIGURE 29 REST OF EUROPE POINT OF CARE DIAGNOSTICS S MARKET 2019-2027 ($ MILLION)
- GEOGRAPHICAL ANALYSIS
- EUROPE
- GERMANY
- FRANCE
- THE UNITED KINGDOM
- ITALY
- SPAIN
- REST OF EUROPE
- EUROPE
- MARKET BY MODE OF PRESCRIPTION
- PRESCRIPTION BASED DEVICES
- OTC BASED DEVICES
- MARKET BY END-USER
- PROFESSIONAL DIAGNOSTIC CENTERS
- RESEARCH LABORATORIES
- HOME CARE
- OTHER END-USER
- MARKET BY PRODUCT TYPE
- GLUCOSE MONITORING KITS
- INFECTIOUS DISEASES TESTING KITS
- PREGNANCY AND FERTILITY TESTING KITS
- HEMATOLOGY TESTING KITS
- CARDIOMETABOLIC MONITORING KITS
- URINALYSIS TESTING KITS
- COAGULATION MONITORING KITS
- TUMOR/CANCER MARKERS TESTING KITS
- CHOLESTEROL TESTING TRIPS
- DRUGS OF ABUSE TESTING KITS
- FECAL OCCULT TESTING KITS
- OTHER PRODUCT
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.